Mb. Morgan et al., Cutaneous epithelioid malignant nerve sheath tumor with rhabdoid features:a histologic, immunohistochemical, and ultrastructural study of three cases, J CUT PATH, 27(10), 2000, pp. 529-534
Introduction: Malignant rhabdoid tumors are morphologically defined as shee
ts of loosely cohesive cells with eccentric nuclei and hyaline, paranuclear
inclusions. Although originally described as a distinctive renal neoplasm
of childhood, these tumors have since been described in all age groups and
in a variety of extrarenal sites. In the latter setting, it is thought that
the rhabdoid phenotype is comprised of histogenetically unrelated tumors,
that regardless of histogenesis, pursue a biologically aggressive behavior.
Methods: We report on the clinical, histologic, immunophenotypic, and ultra
structural characteristics of three cases of cutaneous malignant rhabdoid t
umor.
Results: Each of the cases arose on the trunk or the extremity of elderly m
en. None of the patients had neurofibromatosis. All of the lesions histolog
ically showed sheets of loosely cohesive polygonal cells with eccentric nuc
lei and hyaline paranuclear inclusions. Each of the cases showed the follow
ing immunophenotype: S-100 (+), synaptophysin (+), vimentin (+), alpha smoo
th muscle actin (-), CD-30 (-), HMB-45 (-), and pankeratin (-). Ultrastruct
ure of two Of the cases yielded similar results showing paranuclear filamen
tous aggregates of intermediate filaments, cell membrane dense plaques, and
rudimentary cell junctions consistent with nerve sheath differentiation. T
onofilaments, dense bodies, microtubules, neurosecretory granules, and mela
nosomes were not identified. Each of the patients died of widely metastatic
disease within 1 year of diagnosis.
Conclusions: Cutaneous epithelioid malignant nerve sheath tumor is a potent
ially aggressive tumor capable of showing rhabdoid differentiation thus sim
ulating a variety of neoplasms. Immunophenotyping and ultrastructural analy
sis reliably discriminates these lesions from melanoma, de-differentiated c
arcinoma, lymphoma, and rhabdomyosarcoma.
(C) Munksgaard 2000.